Tag: Marty Makary

FDA Supports Psychedelic-Based Medicines for Treatment-Resistant Depression, PTSD, and Substance Use Disorders

April 26, 2026

FDA Supports Psychedelic-Based Medicines for Treatment-Resistant Depression, PTSD, and Substance Use Disorders

FDA Official to Exit Amid Drug Approval Concerns & Industry Criticism

March 8, 2026

FDA Official to Exit Amid Drug Approval Concerns & Industry Criticism

Sarepta Stock Drops Amid FDA Elevidys Comments

July 19, 2025

Sarepta Stock Drops Amid FDA Elevidys Comments

FDA Drug Approval & Affordability – Makary

July 14, 2025

FDA Drug Approval & Affordability – Makary

Web Analytics